BioCryst Pharmaceuticals, Freshpet rise; Luminar, Integra fall, Monday, 5/6/2024
Time:2024-05-07 17:47:31 Source:opinionsViews(143)
Stocks that traded heavily or had substantial price changes on Monday:
Paramount Global, up 40 cents to $13.29.
The owner of Paramount Pictures and CBS is reportedly considering a sale to Sony Pictures and Apollo Global Management.
Vistra Corp., up $1.75 to $83.24.
The electricity company is being added to the S&P 500 index.
Luminar Technologies Inc., down 1 cent to $1.67.
The maker of technology for self-driving vehicles is cutting 20% of its workforce.
Napco Security Technologies Inc., up $2.83 to $45.30.
The security products and software company beat analysts’ fiscal third-quarter financial results.
BioCryst Pharmaceuticals Inc., up 82 cents to $5.27.
The drugmaker’s first-quarter earnings and revenue beat Wall Street forecasts.
Freshpet Inc., up $11.45 to $121.03.
The seller of fresh pet food beat analysts’ first-quarter financial forecasts.
Integra LifeSciences Holdings Corp., down $5.75 to $23.14.
The medical device maker trimmed its earnings forecast for the year.
Treehouse Foods Inc., down $2.68 to $34.58.
The food maker’s first-quarter loss was bigger than analysts expected.
Previous:They shared a name — but not a future. How two kids fought to escape poverty in Baltimore
Next:More than 40 workers trapped after a building under construction collapsed in South Africa
You may also like
- Two suspects arrested in fatal shooting on Delaware college campus are not students, police say
- Spooks probe whether Chinese
- More people are evacuated after the dramatic eruption of an Indonesian volcano
- Rosie Huntington
- Georgia's attorney general says Savannah overstepped in outlawing guns in unlocked cars
- Argentina launches bid to join forces with NATO: Chainsaw
- Olympic sports bodies criticize track and field's move to pay $50,000 for Paris gold medalists
- European Union official von der Leyen visits the Finland
- A subset of Alzheimer's cases may be caused by two copies of a single gene, new research shows